摘要
In a recent article published in J Hepatol,Younossi et al.provided a comprehensive systematic review and meta-analysis on the prevalence of NAFLD,NASH and advanced fibrosis in patients with type 2 diabetes mellitus(T2DM)across the globe(1).Among the 80 studies included in the final analysis(for a total of 49,419 patients)the prevalence of NAFLD was between 50–70%in all continents,except for Africa,where a prevalence of 30.4%was reported.This lower prevalence of NAFLD in Africa is consistent with prior reports showing a lower prevalence of NAFLD among African-American individuals(2,3).Of note,once African-American patients develop NAFLD,their progression to NASH and advanced fibrosis is similar to other ethnic groups,and still a significant cause of cirrhosis in this population(4).
